Gene content    
MAF ( by HUGO)
V-Maf Avian Musculoaponeurotic Fibrosarcoma Oncogene Homolog
Oncogene
V-Maf Avian Musculoaponeurotic Fibrosarcoma Oncogene Homolog
Proto-Oncogene C-Maf
CCA4
Avian Musculoaponeurotic Fibrosarcoma (MAF) Protooncogene
c-MAF
C-Maf Proto-Oncogene
T Lymphocyte C-Maf Long Form
Transcription Factor Maf
V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog
NCBI: 16q22-q23    Ensembl: 16q23.2
MAF_HUMANSize: 373 amino acidsMass: 38492 Da

  • Subunit: Homodimer or heterodimer with other bHLH-Zip transcription factors. Binds DNA as a homodimer or as a heterodimer. Heterotetramer of two MAF and two USF2. Interacts with PAX6; the interaction is direct. Interacts with MYB; interaction takes place weakly in normal T-cells and increases in T-cells following stimulation through the TCR engagement. Interacts with MYB; the ternary complex formed with MYB and the CD13 promoter is regulated in response to differentiating signals. Interacts with USF2; the interaction inhibits its DNA-binding activity on the L7 promoter. Interacts with CREBBP, EP300 and ETS1 (By similarity)
  • Tissue specificity: Expressed in endothelial cells [IMAGE] Pathway & Disease-focused RT2 Profiler PCR Arrays including MAF: cAMP / Ca2+ Signaling PathwayFinder in human mouse rat Notch Signaling Targets in human mouse rat Th1/Th2 Response in human mouse rat T Helper Cell Dif
  • Function:
    UniProtKB/Swiss-Prot Summary: MAF_HUMAN, O75444 Function: Acts as a transcriptional activator or repressor. Involved in embryonic lens fiber cell development. Recruits the transcriptional coactivators CREBBP and/or EP300 to crystallin promoters leading to up-regulation of crystallin gene during lens fiber cell differentiation. Activates the expression of IL4 in T helper 2 (Th2) cells. Increases T-cell susceptibility to apoptosis by interacting with MYB and decreasing BCL2 expression. Together with PAX6, transactivates strongly the glucagon gene promoter through the G1 element. Activates transcription of the CD13 proximal promoter in endothelial cells. Represses transcription of the CD13 promoter in early stages of myelopoiesis by affecting the ETS1 and MYB cooperative interaction. Involved in the initial chondrocyte terminal differentiation and the disappearance of hypertrophic chondrocytes during endochondral bone development. Binds to the sequence 5'-[GT]G[GC]N[GT]NCTCAGNN-3' in the L7 promoter. Binds to the T-MARE (Maf response element) sites of lens-specific alpha- and beta-crystallin gene promoters. Binds element G1 on the glucagon promoter. Binds an AT-rich region adjacent to the TGC motif (atypical Maf response element) in the CD13 proximal promoter in endothelial cells (By similarity). When overexpressed, represses anti-oxidant response element (ARE)-mediated transcription. Involved either as an oncogene or as a tumor suppressor, depending on the cell context. Binds to the ARE sites of detoxifying enzyme gene promoters
  • Similarity:
    Belongs to the bZIP family. Maf subfamily
                          
    Contains 1 bZIP (basic-leucine zipper) domain [IMAGE]
  • Protein Domain/Family    
    Source ID Domain Name Type
    InterProIPR004826bZIP_MafMaf transcription factorDomain
    IPR004827bZIPBasic-leucine zipper (bZIP) transcription factorDomain
    IPR008917TF_DNA-bdEukaryotic transcription factor, DNA-bindingDomain

    Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process transcription from RNA polymerase II promoter TAS GOA 9616139
    Cellular Component chromatin TAS GOA 9616139

    Disorder & Mutation    
    Source Disease
    SWISS-PROTCataract 21, multiple types (CTRCT21) [MIM:610202]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT21 includes cerulean and pulverulent cataracts. Cerulean cataracts are characterized by peripheral bluish and white opacifications organized in concentric layers with occasional central lesions arranged radially. The opacities are observed in the superficial layers of the fetal nucleus as well as the adult nucleus of the lens. Involvement is usually bilateral. Visual acuity is only mildly reduced in childhood. In adulthood, the opacifications may progress, making lens extraction necessary. Histologically the lesions are described as fusiform cavities between lens fibers which contain a deeply staining granular material. Although the lesions may take on various colors, a dull blue is the most common appearance and is responsible for the designation cerulean cataract. Pulverulent cataracts are characterized by a dust-like, 'pulverised' appearance of the opacities which can be found in any part of the lens. In some cases cataract is associated with microcornea without any other systemic anomaly or dysmorphism. Microcornea is defined by a corneal diameter inferior to 10 mm in both meridians in an otherwise normal eye. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTNote=A chromosomal aberration involving MAF is found in some forms of multiple myeloma (MM). Translocation t(14;16)(q32.3;q23) with an IgH locus

    MAF cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene